13F Data
Security · CUSIP 15089R102

CELATOR PHARMACEUTICALS INC

COM · institutional ownership from 13F filings
13F holders
6
Shares held
3.2M
Value held
$10.4M
New / sold out
5 / 0
Added / reduced
0 / 0
net +2.9M shares

13F holders by quarter

Q4 2013: 6Q1 2014: 7Q2 2014: 11Q3 2014: 13Q4 2014: 14Q1 2015: 15Q2 2015: 16Q3 2015: 20Q4 2015: 21Q1 2016: 58Q2 2016: 119Q3 2016: 0
Q4 2013Q3 2016

Net shares bought by existing holders

Q4 2013: 2.9MQ1 2014: 166.1KQ2 2014: -44.0KQ3 2014: -210.8KQ4 2014: -321.4KQ1 2015: -1.9KQ2 2015: 87.7KQ3 2015: 239.3KQ4 2015: 1.2MQ1 2016: 15.0MQ2 2016: 18.5MQ3 2016: -37.7M
Q4 2013Q3 2016

Top holders · Q4 2013

ManagerSharesValue% of portfolio
CAXTON CORP2,246,469$7.3M4.64%
SABBY MANAGEMENT, LLC679,592$2.2M1.06%
Opaleye Management Inc.310,000$961.0K0.75%
BANK OF AMERICA CORP /DE/467$2.0K0.00%
Tower Research Capital LLC540$2.0K0.00%
UBS AG160$1.0K0.00%

Biggest buyers

ManagerChangeShares changeChange %
CAXTON CORPNew+2,246,469–
SABBY MANAGEMENT, LLCNew+679,592–
Tower Research Capital LLCNew+540–
BANK OF AMERICA CORP /DE/New+467–
UBS AGNew+160–

Biggest sellers

Nothing to show.